img

Global Transdermal Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transdermal Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patch report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Patch market is projected to reach US$ 8726.9 million in 2034, increasing from US$ 6793 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2034. Demand from Rx Channel and OTC Channel are the major drivers for the industry.
Transdermal Patches are mainly classified into the following typesMethyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segment by Application


Rx Channel
OTC Channel

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Patch industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Patch introduction, etc. Transdermal Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transdermal Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Transdermal Patch Market Overview
1.1 Transdermal Patch Product Overview
1.2 Transdermal Patch Market Segment by Type
1.2.1 Methyl Salicylate-based Patch
1.2.2 Rivastigmine Transdermal Patch
1.2.3 Fentanyl Transdermal Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Transdermal Patch
1.2.7 Others
1.3 Global Transdermal Patch Market Size by Type
1.3.1 Global Transdermal Patch Market Size Overview by Type (2018-2034)
1.3.2 Global Transdermal Patch Historic Market Size Review by Type (2018-2024)
1.3.3 Global Transdermal Patch Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Patch Sales Breakdown by Type (2018-2024)
1.4.2 Europe Transdermal Patch Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Transdermal Patch Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Transdermal Patch Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Transdermal Patch Sales Breakdown by Type (2018-2024)
2 Global Transdermal Patch Market Competition by Company
2.1 Global Top Players by Transdermal Patch Sales (2018-2024)
2.2 Global Top Players by Transdermal Patch Revenue (2018-2024)
2.3 Global Top Players by Transdermal Patch Price (2018-2024)
2.4 Global Top Manufacturers Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Patch Market Competitive Situation and Trends
2.5.1 Transdermal Patch Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Patch Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Patch Market
2.8 Key Manufacturers Transdermal Patch Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Patch Status and Outlook by Region
3.1 Global Transdermal Patch Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Transdermal Patch Historic Market Size by Region
3.2.1 Global Transdermal Patch Sales in Volume by Region (2018-2024)
3.2.2 Global Transdermal Patch Sales in Value by Region (2018-2024)
3.2.3 Global Transdermal Patch Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Transdermal Patch Forecasted Market Size by Region
3.3.1 Global Transdermal Patch Sales in Volume by Region (2024-2034)
3.3.2 Global Transdermal Patch Sales in Value by Region (2024-2034)
3.3.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Transdermal Patch by Application
4.1 Transdermal Patch Market Segment by Application
4.1.1 Rx Channel
4.1.2 OTC Channel
4.2 Global Transdermal Patch Market Size by Application
4.2.1 Global Transdermal Patch Market Size Overview by Application (2018-2034)
4.2.2 Global Transdermal Patch Historic Market Size Review by Application (2018-2024)
4.2.3 Global Transdermal Patch Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Patch Sales Breakdown by Application (2018-2024)
4.3.2 Europe Transdermal Patch Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Transdermal Patch Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Transdermal Patch Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Transdermal Patch Sales Breakdown by Application (2018-2024)
5 North America Transdermal Patch by Country
5.1 North America Transdermal Patch Historic Market Size by Country
5.1.1 North America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Transdermal Patch Sales in Volume by Country (2018-2024)
5.1.3 North America Transdermal Patch Sales in Value by Country (2018-2024)
5.2 North America Transdermal Patch Forecasted Market Size by Country
5.2.1 North America Transdermal Patch Sales in Volume by Country (2024-2034)
5.2.2 North America Transdermal Patch Sales in Value by Country (2024-2034)
6 Europe Transdermal Patch by Country
6.1 Europe Transdermal Patch Historic Market Size by Country
6.1.1 Europe Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Transdermal Patch Sales in Volume by Country (2018-2024)
6.1.3 Europe Transdermal Patch Sales in Value by Country (2018-2024)
6.2 Europe Transdermal Patch Forecasted Market Size by Country
6.2.1 Europe Transdermal Patch Sales in Volume by Country (2024-2034)
6.2.2 Europe Transdermal Patch Sales in Value by Country (2024-2034)
7 Asia-Pacific Transdermal Patch by Region
7.1 Asia-Pacific Transdermal Patch Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Patch Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Transdermal Patch Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Transdermal Patch Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Transdermal Patch Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Patch Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Transdermal Patch Sales in Value by Region (2024-2034)
8 Latin America Transdermal Patch by Country
8.1 Latin America Transdermal Patch Historic Market Size by Country
8.1.1 Latin America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Transdermal Patch Sales in Volume by Country (2018-2024)
8.1.3 Latin America Transdermal Patch Sales in Value by Country (2018-2024)
8.2 Latin America Transdermal Patch Forecasted Market Size by Country
8.2.1 Latin America Transdermal Patch Sales in Volume by Country (2024-2034)
8.2.2 Latin America Transdermal Patch Sales in Value by Country (2024-2034)
9 Middle East and Africa Transdermal Patch by Country
9.1 Middle East and Africa Transdermal Patch Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Transdermal Patch Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Transdermal Patch Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Transdermal Patch Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Patch Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Transdermal Patch Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Hisamitsu Pharmaceutical
10.1.1 Hisamitsu Pharmaceutical Company Information
10.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
10.1.5 Hisamitsu Pharmaceutical Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Johnson & Johnson Transdermal Patch Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Transdermal Patch Products Offered
10.3.5 Novartis Recent Development
10.4 UCB Pharma
10.4.1 UCB Pharma Company Information
10.4.2 UCB Pharma Introduction and Business Overview
10.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.4.4 UCB Pharma Transdermal Patch Products Offered
10.4.5 UCB Pharma Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Mylan Transdermal Patch Products Offered
10.5.5 Mylan Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Information
10.6.2 Teva Pharmaceutical Introduction and Business Overview
10.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
10.6.5 Teva Pharmaceutical Recent Development
10.7 Nitto Denko
10.7.1 Nitto Denko Company Information
10.7.2 Nitto Denko Introduction and Business Overview
10.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Nitto Denko Transdermal Patch Products Offered
10.7.5 Nitto Denko Recent Development
10.8 Grünenthal
10.8.1 Grünenthal Company Information
10.8.2 Grünenthal Introduction and Business Overview
10.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Grünenthal Transdermal Patch Products Offered
10.8.5 Grünenthal Recent Development
10.9 IBSA Group
10.9.1 IBSA Group Company Information
10.9.2 IBSA Group Introduction and Business Overview
10.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.9.4 IBSA Group Transdermal Patch Products Offered
10.9.5 IBSA Group Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.10.4 GSK Transdermal Patch Products Offered
10.10.5 GSK Recent Development
10.11 Luye Pharma Group
10.11.1 Luye Pharma Group Company Information
10.11.2 Luye Pharma Group Introduction and Business Overview
10.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Luye Pharma Group Transdermal Patch Products Offered
10.11.5 Luye Pharma Group Recent Development
10.12 Pfizer
10.12.1 Pfizer Company Information
10.12.2 Pfizer Introduction and Business Overview
10.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Pfizer Transdermal Patch Products Offered
10.12.5 Pfizer Recent Development
10.13 Chattem
10.13.1 Chattem Company Information
10.13.2 Chattem Introduction and Business Overview
10.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Chattem Transdermal Patch Products Offered
10.13.5 Chattem Recent Development
10.14 Dr Reddy’s Laboratories
10.14.1 Dr Reddy’s Laboratories Company Information
10.14.2 Dr Reddy’s Laboratories Introduction and Business Overview
10.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
10.14.5 Dr Reddy’s Laboratories Recent Development
10.15 Bayer
10.15.1 Bayer Company Information
10.15.2 Bayer Introduction and Business Overview
10.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Bayer Transdermal Patch Products Offered
10.15.5 Bayer Recent Development
10.16 Mundipharma
10.16.1 Mundipharma Company Information
10.16.2 Mundipharma Introduction and Business Overview
10.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Mundipharma Transdermal Patch Products Offered
10.16.5 Mundipharma Recent Development
10.17 Endo International
10.17.1 Endo International Company Information
10.17.2 Endo International Introduction and Business Overview
10.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Endo International Transdermal Patch Products Offered
10.17.5 Endo International Recent Development
10.18 Beijing Tide Pharmaceutical
10.18.1 Beijing Tide Pharmaceutical Company Information
10.18.2 Beijing Tide Pharmaceutical Introduction and Business Overview
10.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
10.18.5 Beijing Tide Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Patch Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Patch Industrial Chain Analysis
11.4 Transdermal Patch Market Dynamics
11.4.1 Transdermal Patch Industry Trends
11.4.2 Transdermal Patch Market Drivers
11.4.3 Transdermal Patch Market Challenges
11.4.4 Transdermal Patch Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Patch Distributors
12.3 Transdermal Patch Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Methyl Salicylate-based Patch
Table 2. Major Company of Rivastigmine Transdermal Patch
Table 3. Major Company of Fentanyl Transdermal Patch
Table 4. Major Company of Lidocaine Patch
Table 5. Major Company of Diclofenac Patch
Table 6. Major Company of Nicotine Transdermal Patch
Table 7. Major Company of Others
Table 8. Global Transdermal Patch Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Transdermal Patch Sales by Type (2018-2024) & (M Pcs)
Table 10. Global Transdermal Patch Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Transdermal Patch Sales by Type (2018-2024) & (US& Million)
Table 12. Global Transdermal Patch Market Share in Value by Type (2018-2024)
Table 13. Global Transdermal Patch Price by Type (2018-2024) & (USD/Pc)
Table 14. Global Transdermal Patch Sales by Type (2024-2034) & (M Pcs)
Table 15. Global Transdermal Patch Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Transdermal Patch Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Transdermal Patch Sales Market Share in Value by Type (2024-2034)
Table 18. Global Transdermal Patch Price by Type (2024-2034) & (USD/Pc)
Table 19. North America Transdermal Patch Sales by Type (2018-2024) & (M Pcs)
Table 20. North America Transdermal Patch Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Transdermal Patch Sales (M Pcs) by Type (2018-2024)
Table 22. Europe Transdermal Patch Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Transdermal Patch Sales (M Pcs) by Type (2018-2024)
Table 24. Asia-Pacific Transdermal Patch Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Transdermal Patch Sales (M Pcs) by Type (2018-2024)
Table 26. Latin America Transdermal Patch Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Transdermal Patch Sales (M Pcs) by Type (2018-2024)
Table 28. Middle East and Africa Transdermal Patch Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Transdermal Patch Sales by Company (2018-2024) & (M Pcs)
Table 30. Global Transdermal Patch Sales Share by Company (2018-2024)
Table 31. Global Transdermal Patch Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Transdermal Patch Revenue Share by Company (2018-2024)
Table 33. Global Market Transdermal Patch Price by Company (2018-2024) & (USD/Pc)
Table 34. Global Transdermal Patch Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2022)
Table 37. Date of Key Manufacturers Enter into Transdermal Patch Market
Table 38. Key Manufacturers Transdermal Patch Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Transdermal Patch Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Transdermal Patch Sales by Region (2018-2024) & (M Pcs)
Table 42. Global Transdermal Patch Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Transdermal Patch Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Transdermal Patch Sales Market Share in Value by Region (2018-2024)
Table 45. Global Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2018-2024)
Table 46. Global Transdermal Patch Sales by Region (2024-2034) & (M Pcs)
Table 47. Global Transdermal Patch Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Transdermal Patch Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Transdermal Patch Sales Market Share in Value by Region (2024-2034)
Table 50. Global Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2024-2034)
Table 51. Global Transdermal Patch Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Transdermal Patch Sales by Application (2018-2024) & (M Pcs)
Table 53. Global Transdermal Patch Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Transdermal Patch Sales Market Share in Value by Application (2018-2024)
Table 56. Global Transdermal Patch Price by Application (2018-2024) & (USD/Pc)
Table 57. Global Transdermal Patch Sales by Application (2024-2034) & (M Pcs)
Table 58. Global Transdermal Patch Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Transdermal Patch Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Transdermal Patch Sales Market Share in Value by Application (2024-2034)
Table 61. Global Transdermal Patch Price by Application (2024-2034) & (USD/Pc)
Table 62. North America Transdermal Patch Sales by Application (2018-2024) (M Pcs)
Table 63. North America Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Transdermal Patch Sales by Application (2018-2024) (M Pcs)
Table 65. Europe Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Transdermal Patch Sales by Application (2018-2024) (M Pcs)
Table 67. Asia-Pacific Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Transdermal Patch Sales by Application (2018-2024) (M Pcs)
Table 69. Latin America Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Transdermal Patch Sales by Application (2018-2024) (M Pcs)
Table 71. Middle East and Africa Transdermal Patch Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Transdermal Patch Sales by Country (2018-2024) & (M Pcs)
Table 73. North America Transdermal Patch Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Transdermal Patch Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Transdermal Patch Sales Market Share in Value by Country (2018-2024)
Table 76. North America Transdermal Patch Sales by Country (2024-2034) & (M Pcs)
Table 77. North America Transdermal Patch Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Transdermal Patch Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Transdermal Patch Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Transdermal Patch Sales by Country (2018-2024) & (M Pcs)
Table 81. Europe Transdermal Patch Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Transdermal Patch Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Transdermal Patch Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Transdermal Patch Sales by Country (2024-2034) & (M Pcs)
Table 85. Europe Transdermal Patch Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Transdermal Patch Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Transdermal Patch Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Transdermal Patch Sales by Region (2018-2024) & (M Pcs)
Table 89. Asia-Pacific Transdermal Patch Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Transdermal Patch Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Transdermal Patch Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Transdermal Patch Sales by Region (2024-2034) & (M Pcs)
Table 93. Asia-Pacific Transdermal Patch Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Transdermal Patch Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Transdermal Patch Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Transdermal Patch Sales by Country (2018-2024) & (M Pcs)
Table 97. Latin America Transdermal Patch Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Transdermal Patch Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Transdermal Patch Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Transdermal Patch Sales by Country (2024-2034) & (M Pcs)
Table 101. Latin America Transdermal Patch Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Transdermal Patch Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Transdermal Patch Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Transdermal Patch Sales by Country (2018-2024) & (M Pcs)
Table 105. Middle East and Africa Transdermal Patch Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Transdermal Patch Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Transdermal Patch Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Transdermal Patch Sales by Country (2024-2034) & (M Pcs)
Table 109. Middle East and Africa Transdermal Patch Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Transdermal Patch Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Transdermal Patch Sales Market Share in Value by Country (2024-2034)
Table 112. Hisamitsu Pharmaceutical Company Information
Table 113. Hisamitsu Pharmaceutical Introduction and Business Overview
Table 114. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 115. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 116. Hisamitsu Pharmaceutical Recent Development
Table 117. Johnson & Johnson Company Information
Table 118. Johnson & Johnson Introduction and Business Overview
Table 119. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 120. Johnson & Johnson Transdermal Patch Product
Table 121. Johnson & Johnson Recent Development
Table 122. Novartis Company Information
Table 123. Novartis Introduction and Business Overview
Table 124. Novartis Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 125. Novartis Transdermal Patch Product
Table 126. Novartis Recent Development
Table 127. UCB Pharma Company Information
Table 128. UCB Pharma Introduction and Business Overview
Table 129. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 130. UCB Pharma Transdermal Patch Product
Table 131. UCB Pharma Recent Development
Table 132. Mylan Company Information
Table 133. Mylan Introduction and Business Overview
Table 134. Mylan Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 135. Mylan Transdermal Patch Product
Table 136. Mylan Recent Development
Table 137. Teva Pharmaceutical Company Information
Table 138. Teva Pharmaceutical Introduction and Business Overview
Table 139. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 140. Teva Pharmaceutical Transdermal Patch Product
Table 141. Teva Pharmaceutical Recent Development
Table 142. Nitto Denko Company Information
Table 143. Nitto Denko Introduction and Business Overview
Table 144. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 145. Nitto Denko Transdermal Patch Product
Table 146. Nitto Denko Recent Development
Table 147. Grünenthal Company Information
Table 148. Grünenthal Introduction and Business Overview
Table 149. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 150. Grünenthal Transdermal Patch Product
Table 151. Grünenthal Recent Development
Table 152. IBSA Group Company Information
Table 153. IBSA Group Introduction and Business Overview
Table 154. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 155. IBSA Group Transdermal Patch Product
Table 156. IBSA Group Recent Development
Table 157. GSK Company Information
Table 158. GSK Introduction and Business Overview
Table 159. GSK Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 160. GSK Transdermal Patch Product
Table 161. GSK Recent Development
Table 162. Luye Pharma Group Company Information
Table 163. Luye Pharma Group Introduction and Business Overview
Table 164. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 165. Luye Pharma Group Transdermal Patch Product
Table 166. Luye Pharma Group Recent Development
Table 167. Pfizer Company Information
Table 168. Pfizer Introduction and Business Overview
Table 169. Pfizer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 170. Pfizer Transdermal Patch Product
Table 171. Pfizer Recent Development
Table 172. Chattem Company Information
Table 173. Chattem Introduction and Business Overview
Table 174. Chattem Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 175. Chattem Transdermal Patch Product
Table 176. Chattem Recent Development
Table 177. Dr Reddy’s Laboratories Company Information
Table 178. Dr Reddy’s Laboratories Introduction and Business Overview
Table 179. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 180. Dr Reddy’s Laboratories Transdermal Patch Product
Table 181. Dr Reddy’s Laboratories Recent Development
Table 182. Bayer Company Information
Table 183. Bayer Introduction and Business Overview
Table 184. Bayer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 185. Bayer Transdermal Patch Product
Table 186. Bayer Recent Development
Table 187. Mundipharma Company Information
Table 188. Mundipharma Introduction and Business Overview
Table 189. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 190. Mundipharma Transdermal Patch Product
Table 191. Mundipharma Recent Development
Table 192. Endo International Company Information
Table 193. Endo International Introduction and Business Overview
Table 194. Endo International Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 195. Endo International Transdermal Patch Product
Table 196. Endo International Recent Development
Table 197. Beijing Tide Pharmaceutical Company Information
Table 198. Beijing Tide Pharmaceutical Introduction and Business Overview
Table 199. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2018-2024)
Table 200. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 201. Beijing Tide Pharmaceutical Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Transdermal Patch Market Trends
Table 205. Transdermal Patch Market Drivers
Table 206. Transdermal Patch Market Challenges
Table 207. Transdermal Patch Market Restraints
Table 208. Transdermal Patch Distributors List
Table 209. Transdermal Patch Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Transdermal Patch Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Transdermal Patch Sales Status and Outlook (2018-2034) & (M Pcs)
Figure 5. Product Picture of Methyl Salicylate-based Patch
Figure 6. Global Methyl Salicylate-based Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 7. Product Picture of Rivastigmine Transdermal Patch
Figure 8. Global Rivastigmine Transdermal Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 9. Product Picture of Fentanyl Transdermal Patch
Figure 10. Global Fentanyl Transdermal Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 11. Product Picture of Lidocaine Patch
Figure 12. Global Lidocaine Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 13. Product Picture of Diclofenac Patch
Figure 14. Global Diclofenac Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 15. Product Picture of Nicotine Transdermal Patch
Figure 16. Global Nicotine Transdermal Patch Sales YoY Growth (2018-2034) & (M Pcs)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2018-2034) & (M Pcs)
Figure 19. Global Transdermal Patch Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Transdermal Patch Sales Market Share by Type in 2022 & 2034
Figure 21. North America Transdermal Patch Sales Market Share in Volume by Type in 2022
Figure 22. North America Transdermal Patch Sales Market Share in Value by Type in 2022
Figure 23. Europe Transdermal Patch Sales Market Share in Volume by Type in 2022
Figure 24. Europe Transdermal Patch Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Transdermal Patch Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Transdermal Patch Sales Market Share in Value by Type in 2022
Figure 27. Latin America Transdermal Patch Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Transdermal Patch Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Transdermal Patch Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Transdermal Patch Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Patch Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Patch Revenue in 2022
Figure 33. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Rx Channel
Figure 35. Global Rx Channel Sales YoY Growth (2018-2034) & (M Pcs)
Figure 36. Product Picture of OTC Channel
Figure 37. Global OTC Channel Sales YoY Growth (2018-2034) & (M Pcs)
Figure 38. Global Transdermal Patch Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Transdermal Patch Sales Market Share by Application in 2022 & 2034
Figure 40. North America Transdermal Patch Sales Market Share in Volume by Application in 2022
Figure 41. North America Transdermal Patch Sales Market Share in Value by Application in 2022
Figure 42. Europe Transdermal Patch Sales Market Share in Volume by Application in 2022
Figure 43. Europe Transdermal Patch Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Transdermal Patch Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Transdermal Patch Sales Market Share in Value by Application in 2022
Figure 46. Latin America Transdermal Patch Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Transdermal Patch Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Transdermal Patch Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Transdermal Patch Manufacturing Cost Structure
Figure 51. Transdermal Patch Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries